Midwest BioResearch LLC

Midwest BioResearch Hires Former FDA Investigator James Plucinski to Guide Client Quality Assurance

Published in Medical Letter on the CDC and FDA, February 3rd, 2008

Midwest BioResearch LLC (MBR), a contract research organization focused on drug disposition and toxicology, announced the addition of James Plucinski as its new Quality Assurance Manager. Plucinski, a former investigator with the Food and Drug Administration (FDA), will manage MBR's quality assurance program.

Plucinski brings seven years of quality assurance experience to MBR, including more than three years as an investigator with the FDA. Jim has experience working in both GMP and GLP environments, as well as conducting GMP and GLP audits of both pharmaceutical and medical device firms, and GCP audits of clinical investigators. Prior to MBR, Plucinski worked as a...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA

Source: Medical Letter on the CDC and FDA (2008-02-03)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry